Qi‐Dong Xia
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Ubiquitin and proteasome pathways 5
- Metabolism, Diabetes, and Cancer 4
-
- Kidney Stones and Urolithiasis Treatments 11
- Renal cell carcinoma treatment 4
- Co-authors
- Shaogang Wang (73 shared papers)Jian‐Xuan Sun (54 shared papers)Jia Hu (21 shared papers)Jin‐Zhou Xu (53 shared papers)Junlin Lu (17 shared papers)Chen‐Qian Liu (43 shared papers)Yang Xun (13 shared papers)Cong Li (9 shared papers)
- Journals
- Frontiers in Immunology (6 papers)Frontiers in Oncology (5 papers)Journal of the American Chemical Society (4 papers)Journal of Oncology (4 papers)Frontiers in Cell and Developmental Biology (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Qi‐Dong Xia
93 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 197
- Immunology 253
- Oncology 251
- Pulmonary and Respiratory Medicine 278
- Pharmacology 67
Countries citing papers authored by Qi‐Dong Xia
This map shows the geographic impact of Qi‐Dong Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi‐Dong Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi‐Dong Xia more than expected).
Fields of papers citing papers by Qi‐Dong Xia
This network shows the impact of papers produced by Qi‐Dong Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi‐Dong Xia. The network helps show where Qi‐Dong Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi‐Dong Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 206 | |
| 2 | 2020 | 179 | |
| 3 | 2021 | 89 | |
| 4 | 2020 | 49 | |
| 5 | 2022 | 43 | |
| 6 | 2022 | 42 | |
| 7 | 2020 | 32 | |
| 8 | 2022 | 30 | |
| 9 | 2021 | 28 | |
| 10 | 2023 | 24 | |
| 11 | 2022 | 24 | |
| 12 | 2022 | 23 | |
| 13 | 2022 | 23 | |
| 14 | 2022 | 23 | |
| 15 | 2022 | 22 | |
| 16 | 2023 | 19 | |
| 17 | 2020 | 18 | |
| 18 | 2022 | 18 | |
| 19 | 2023 | 18 | |
| 20 | 2023 | 17 |
About Qi‐Dong Xia
Qi‐Dong Xia is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Biotechnology, having authored 102 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (13 papers), Kidney Stones and Urolithiasis Treatments (11 papers), Cancer, Lipids, and Metabolism (10 papers), Virus-based gene therapy research (7 papers), Cancer Research and Treatments (6 papers), Ubiquitin and proteasome pathways (5 papers), Renal cell carcinoma treatment (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Cancer Research (197 citations), Immunology (253 citations), Oncology (251 citations), Pulmonary and Respiratory Medicine (278 citations) and Pharmacology (67 citations). Qi‐Dong Xia has collaborated with scholars based in China and United States. Frequent co-authors include Shaogang Wang, Jian‐Xuan Sun, Jia Hu, Jin‐Zhou Xu, Junlin Lu, Chen‐Qian Liu, Yang Xun, Cong Li, Ye An and Yuchao Lu. Their work appears in journals such as Frontiers in Immunology, Frontiers in Oncology, Journal of the American Chemical Society, Journal of Oncology and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.